Maternal exposure to perfluorinated acids and fetal growth

Journal of Exposure Science and Environmental Epidemiology

Volumn 20, Issue 7, 2010, Pages 589-597

  Hamm, Michele P ^a   Cherry, Nicola M ^a   Chan, Emily ^a   Martin, Jonathan W ^a   Burstyn, Igor ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

fetal growth restriction; perfluorinated acid; preterm delivery; small for gestational age

Indexed keywords

ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROHEXANESULFONIC ACID; PERFLUOROOCTANE SULFONIC ACID; PERFLUOROOCTANOIC ACID; SULFONIC ACID DERIVATIVE;

ARTICLE; BIRTH WEIGHT; BLOOD; COHORT ANALYSIS; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS DEVELOPMENT; GESTATIONAL AGE; HUMAN; MALE; NEWBORN; POISSON DISTRIBUTION; PREGNANCY; SMALL FOR DATE INFANT; STATISTICAL MODEL;

ALKANESULFONIC ACIDS; BIRTH WEIGHT; COHORT STUDIES; FEMALE; FETAL DEVELOPMENT; FLUOROCARBONS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LINEAR MODELS; MALE; MATERNAL EXPOSURE; OCTANOIC ACIDS; POISSON DISTRIBUTION; PREGNANCY; SULFONIC ACIDS;

ANIMALIA;

EID: 77958485579     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/jes.2009.57     Document Type: Article

References (26)

1. Apelberg B.J., Witter F.R., Herstman J.B., Calafat A.M., Halden R.U., and Needham L.L., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 2007: 115: 1670-1676.
2. Case M.T., York R.G., and Christian M.S. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol 2001: 20: 101-109.
3. Chan E., Sandhu M., Benskin J.P., Ralitsch M., Thibault N., and Birkholz D., et al. Endogenous high-performance liquid chromatography/tandem mass spectrometry interferences and the case of perfluorohexane sulfonate (PFHxS) in human serum; are we overestimating exposure? Rapid Commun Mass Spectrom 2009: 23: 1405-1410.
4. Dupont W.D., and Plummer W.D. PS power and sample size program available for free on the Internet. Controlled Clin Trials 1997: 18: 274.
5. Era S., Harada K.H., Toyoshima M., Inoue K., Minata M., and Saito N., et al. Cleft palate caused by perfluorooctane sulfonate is caused mainly by extrinsic factors. Toxicology 2009: 256: 42-47.
6. Fei C., McLaughlin J.K., Tarone R.E., and Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 2007: 115: 1677-1682.
7. Frisbee S.J., Brooks A.P., Maher A., Flensborg P., Arnold S., and Fletcher T., et al. The C8 Health Project: design, methods, and participants. Environ Health Perspect 2009 doi: 10.1289/ehp.0800379.
8. Gabos S., Zemanek M., Cheperdak L., Kinniburgh D., Lee B., and Hrudey S., et al. Chemical biomonitoring in serum of pregnant women in Alberta (2005). A final report submitted to Alberta Health and Wellness May 2008 http://www.health.alberta.ca/documents/Chemical-Biomonitoring-2008.pdf., 2008.
9. Grice M.M., Alexander B.H., Hoffbeck R., and Kampa D.M. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 2007: 49: 722-729.
10. Hansen K.J., Clemen L.A., Ellefson M.E., and Johnson H.O. Compoundspecific, quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol 2001: 35: 766-770.
11. Houde M., Martin J.W., Letcher R.J., Solomon K.R., and Muir D.C.G. Biological monitoring of perfluoroalkyl substances: a review. Environ Sci Technol 2006: 40: 3463-3473.
12. Inoue K., Okada F., Ito R., Kato S., Sasaki S., and Nakajima S., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 2004: 112: 1204-1207.
13. Kennedy G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., and Perkins R.G., et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol 2004: 34: 351-384.
14. Kramer M.S., Platt R.W., Wen S.W., Joseph K.S., Allen A., and Abrahamowicz M., et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001: 108: E35.
15. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., and Stanton M.E., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 2003: 74: 382-392.
16. Midasch O., Drexler H., Hart N., Beckmann M.W., and Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 2007: 80: 643-648.
17. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., and Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 2008: 108: 56-62.
18. Nolan L.A., Nolan J.M., Shofer F.S., Rodway N.V., and Emmett E.A. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 2009: 27: 231-238.
19. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., and Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexane sulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007: 115: 1298-1305.
20. Olsen G.W., Mair D.C., Church T.R., Ellefson M.E., Reagen W.K., and Boyd T.M., et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol 2008: 42: 4989-4995.
21. Olsen G.W., Butenhoff J.L., and Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 2009: 27: 212-230.
22. Savitz D.A. Biomarkers of perfluorinated chemicals and birth weight. Environ Health Perspect 2007: 115: A528-A529.
23. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., and Richards J.H., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 2003: 74: 369-381.
24. Tough S., Tofflemire K., and Jack M. Reproduction in Alberta: a look at the preconception, prenatal and postnatal periods, 2006. Prepared for the Alberta Centre for Child, Family and Community Research. http://www.research 4children.com/public/data/documents/ReproductioninAlberta20060620pdf.pdf (updated March 2007, viewed 13 October, 2009).
25. Washino N., Saijo Y., Sasaki S., Kato S., Ban S., and Konishi K., et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 2009: 117: 660-667.
26. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004: 159: 702-706.